跳轉至內容
Merck
  • Eosinophilic lung disease induced by bicalutamide: a case report and review of the medical literature.

Eosinophilic lung disease induced by bicalutamide: a case report and review of the medical literature.

Chest (1998-03-14)
P W Wong, N Macris, L DiFabrizio, N S Seriff
摘要

A 69-year-old man with advanced prostate cancer was receiving antiandrogen therapy (bicalutamide [Casodex]). He developed dyspnea, peripheral eosinophilia and bilateral pulmonary interstitial infiltrates. Transbronchial biopsy confirmed pulmonary eosinophilia. Withdrawal of bicalutamide and initiation of steroid therapy resulted in clinical improvement.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
比卡鲁胺 (CDX), ≥98% (HPLC), powder
比卡鲁胺, European Pharmacopoeia (EP) Reference Standard
比卡鲁胺, European Pharmacopoeia (EP) Reference Standard